In vitro and in vivo comparison of [3H](+)-PHNO and [3H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: A method to distinguish dopamine D3 from D2 receptor sites: A method to distinguish dopamine D3 from D2 receptor sites-Reference-Cited by-同舟云学术

In vitro and in vivo comparison of [3H](+)-PHNO and [3H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: A method to distinguish dopamine D3 from D2 receptor sites: A method to distinguish dopamine D3 from D2 receptor sites

Published:2010-11-09 Issue:6 Volume:65 Page:467-478
ISSN:0887-4476
Container-title:Synapse
language:en
Short-container-title:Synapse

Author:

Kiss Béla,Horti Ferenc,Bobok Amrita

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/syn.20867/fullpdf

Reference43 articles.

1. Dopamine receptor distribution in the rat CNS: Elucidation using anti-peptide antisera directed against D1A and D3 subtypes;Ariano;Brain Res,1994

2. Binding of [3H]PD 128907, a putatively selective ligand for the D3 dopamine receptor, in rat brain: A receptor binding and quantitative autoradiographic study;Bancroft;Neuropsychopharmacology,1998

3. Evidence for a functional role of the dopamine D3 receptors in the cerebellum;Barik;Brain Res,1996

4. Microanatomical localization of dopamine receptor protein immunoreactivity in the rat cerebellar cortex;Barili;Brain Res,2000

5. Decreased locomotor activity after microinjection of dopamine D2/D3 receptor agonists and antagonists into lobule 9/10 of the cerebellum: A D3 receptor mediated effect?;Boulay;Prog Neuropsychopharmacol Biol Psychiatry,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interaction of the preferential D3 agonist (+)PHNO with dopamine D3-D2 receptor heterodimers and diverse classes of monoamine receptor: relevance for PET imaging;European Journal of Pharmacology;2022-06

2. Potential Mechanisms for Why Not All Antipsychotics Are Able to Occupy Dopamine D3 Receptors in the Brain in vivo;Frontiers in Psychiatry;2022-03-24

3. Therapeutic Interventions to Mitigate Mitochondrial Dysfunction and Oxidative Stress–Induced Damage in Patients with Bipolar Disorder;International Journal of Molecular Sciences;2022-02-06

4. Current Perspectives on Selective Dopamine D3 Receptor Antagonists/Partial Agonists as Pharmacotherapeutics for Opioid and Psychostimulant Use Disorders;Therapeutic Applications of Dopamine D3 Receptor Function;2022

5. The Cerebellar Dopaminergic System;Frontiers in Systems Neuroscience;2021-08-05